Mitigating factors and metabolic mechanisms in fructose-induced nonalcoholic fatty liver disease: the next challenge

Marc Hellerstein

doi:10.3945/ajcn.112.049650

Related publications

Article2017

Lipocalin-2 in Fructose-Induced Fatty Liver Disease

Jessica Lambertz, Thorsten Berger, Tak W. Mak, Josef van Helden, Ralf Weiskirchen

Article2015

Nonalcoholic Fatty Liver Disease and Vascular Function

Michelle T. Long, Na Wang, Martin G. Larson, Gary F. Mitchell, Joseph Palmisano, Ramachandran S. Vasan, Udo Hoffmann, Elizabeth K. Speliotes, Joseph A. Vita, Emelia Benjamin, Caroline S. Fox, Naomi M. Hamburg

Article2020

Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease

Mei‐Fei Yueh, Feng He, Chen Chen, Catherine Vu, Anupriya Tripathi, Rob Knight, Michael Karin, Shujuan Chen, Robert H. Tukey

Article2021

Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota

Karolina Drożdż, Katarzyna Nabrdalik, Weronika Hajzler, Hanna Kwiendacz, Janusz Gumprecht, Professor Gregory Lip

Article2012

Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma

Labrini Papanastasiou, Θεοδώρα Παππά, Christianna Samara, Glyceria Apostolopoulou, Vaios Tsiavos, Αthina Markou, Krystallenia Alexandraki, George Piaditis, George Chrousos, Gregory Kaltsas